Cities Index.
Memorandum

San Jose City Council
August 26, 2025

Document
Memorandum
Meeting
August 26, 2025
Body
San Jose City Council
Pages
2
Original file
179 KB
Text extracted from the city's file for reading and search. Open the original on legistar.granicus.com. That file is the official record.

COUNCIL AGENDA: 08/26/2025
FILE: 25-925
ITEM: 2.27
T-42879 / 2238604
TO
: HONORABLE MAYOR AND CITY

COUNCIL
FROM: NORA FRIMANN
City Attorney
SUBJECT: In re: Purdue Pharma, LP, et al;
In Re: National Prescription
Opiate Litigation
DATE: August 20, 2025

RECOMMENDAT
ION
A.

Approve the Purdue Bankruptcy Plan and participate in a settlement with members of the Sackler family; and
B. Participate in settlements with opioi d manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Syn Pharma, Zydus, and Sandoz; and C. Direct the City Attorney to execut e all necessary documents and agreements on behalf of the City of San José.

BACKGROUND
States and local public
entities throughout the country, including the City of San Jose, brought lawsuits against manufacturers, distributors, and pharmacies responsible for contributing to the opioid epidemic.

ANALYSIS
Purdue Pharma, owned by the Sackler family, manufactured Oxycontin. Purdue filed for bankruptcy in 2019. The proposed settlement consists of: (1) a settlement through the bankruptcy plan for a total of $1.5 billion, and (2) a settlement directly with the Sackler family for a total of $6.5 billion. It i
s estimated that San José can expect to receive up to
$ 1.3 million from these settlements.

Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Syn Pharma, and Zydus are manufacturers of opioids who have agreed to pay a total of $844 million in cash settlements. It is estimated that San José’s share of the cash settlement proceeds would be approximately $253,000. Sandoz manufactured generic fentanyl transdermal August 18, 2025
Subject: In re: Purdue Pharma, LP, et al; In Re: National Prescription Opiate Litigation

Page 2 ends

T-42879 / 2238604
patches. It had a relatively small share of the market and exited the opioid market entirely in 2019. Sandoz agreed to pay a total of $99.5 million.

Participation in these settlements would result in the recovery of approximately $1.5 million for the prevention and remediation of harms related to opioid misuse. The City is unlikely to achieve more favorable results by declining to participate in the settlement.

PUBLIC OUTREACH/INTEREST

This memorandum will be posted on the City’s website for the August 26, 2025, agenda.

CEQA

Not a Project, File No. PP17-003, Agreements/Contracts (New or Amended) resulting in no physical changes to the environment.

By: /s/ Nora Frimann

NORA FRIMANN
City Attorney

cc: Jennifer Maguire, City Manager

For questions, please contact NORA FRIMANN, City Attorney, at (408) 535-1900.

← All documents from this meeting